Medicina
Département
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublications en collaboration avec des chercheurs de AstraZeneca (United Kingdom) (13)
2023
-
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811
-
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)
Future oncology (London, England), Vol. 19, Núm. 38, pp. 2505-2516
2022
-
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study
Respiratory Medicine, Vol. 200
2020
-
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort
Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148
2019
-
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59
2015
2010
-
Extended-release quetiapine fumarate (quetiapine XR): A once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo-and active-controlled study
International Journal of Neuropsychopharmacology, Vol. 13, Núm. 3, pp. 305-320
2008
-
Validity and reliability of the Spanish versions of the Bech-Rafaelsen's mania and melancholia scales for bipolar disorders
Acta Psychiatrica Scandinavica, Vol. 117, Núm. 3, pp. 207-215
2007
-
Seasons and other factors affecting the quality of life of asthmatic children
Journal of Investigational Allergology and Clinical Immunology, Vol. 17, Núm. 4, pp. 249-256
-
Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)
Journal of Affective Disorders, Vol. 102, Núm. 1-3, pp. 93-99
-
The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia
International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 3, pp. 222-232
-
The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting
International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 2, pp. 146-150
2003
-
Burden of illness of Crohn's disease in Spain
Digestive and Liver Disease, Vol. 35, Núm. 12, pp. 853-861